Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study - Quiz - MDSpire

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study

  • By

  • Kimberly A Brown

  • Stuart C Gordon

  • Yichu Wang

  • Trueman Wu

  • Sheri Trudeau

  • Loralee B Rupp

  • Yihe G Daida

  • Mark A Schmidt

  • Mei Lu

  • March 27, 2026

Share

Original Source(s)

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study

  • by Kimberly A Brown, Stuart C Gordon, Yichu Wang, Trueman Wu, Sheri Trudeau, Loralee B Rupp, Yihe G Daida, Mark A Schmidt, Mei Lu

  • March 27, 2026

Related Content

Editorial: The MASLD spectrum: an emerging epidemic of cardiometabolic and extra-hepatic dimensions

Prediction models for mortality in patients with acute on chronic liver failure: systematic review and critical appraisal

Clinical and CT/MRI features of hepatic AL amyloidosis: preliminary experience in 10 cases